Imugene Ltd has released a press release.
Partnership to Develop Mimotope Immuno-Oncology Platform
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Imugene
Later from Imugene
- Manufacturing Update
- Imugene Announces Successful Capital Raising
- Regulatory package submission for Her-Vaxx in Hong Kong
- Imugene Receives Institutional Review Board Approval
- Imugene Receives Approval to Start Gastric Cancer Study
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene